Todd Harris, Chief Executive Officer at Tyra Biosciences, Inc. (TYRA), sold 47,880 shares at $16.78 ($814K) on 2023-06-23, disclosed to the SEC on 2023-06-26.
Scheduled sale ($814k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.98 | 2,978 | $51K | 6.2% |
| 2 | $16.98 | 2,978 | $51K | 6.2% |
| 3 | $17.39 | 500 | $9K | 1.1% |
| 4 | $16.78 | 14,231 | $239K | 29.3% |
| 5 | $16.78 | 14,231 | $239K | 29.3% |
| 6 | $17.51 | 6,481 |
| $113K |
| 13.9% |
| 7 | $17.51 | 6,481 | $113K | 13.9% |
| Total | $17.01 avg | 47,880 | $814K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |